0000950170-23-068925.txt : 20231208 0000950170-23-068925.hdr.sgml : 20231208 20231208082003 ACCESSION NUMBER: 0000950170-23-068925 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231206 FILED AS OF DATE: 20231208 DATE AS OF CHANGE: 20231208 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Woods Keith CENTRAL INDEX KEY: 0001996804 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40603 FILM NUMBER: 231473970 MAIL ADDRESS: STREET 1: C/O X4 PHARMACEUTICALS INC. STREET 2: 61 NORTH BEACON STREET 4TH FLOOR CITY: BOSTON STATE: MA ZIP: 02134 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TScan Therapeutics, Inc. CENTRAL INDEX KEY: 0001783328 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 825282075 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 880 WINTER STREET CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 857-399-9500 MAIL ADDRESS: STREET 1: 880 WINTER STREET CITY: WALTHAM STATE: MA ZIP: 02451 4 1 ownership.xml 4 X0508 4 2023-12-06 0001783328 TScan Therapeutics, Inc. TCRX 0001996804 Woods Keith C/O TSCAN THERAPEUTICS, INC. 830 WINTER STREET WALTHAM MA 02451 true false false false false Stock Option (Right to Buy) 6.74 2023-12-06 4 A false 17500 0.00 A 2033-12-05 Voting Common Stock 17500 17500 D The shares subject to this option shall vest and become exercisable in full upon the earlier to occur of (i) December 6, 2024 and (ii) the next annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service at such time. /s/ Zoran Zdraveski, Attorney-in-Fact 2023-12-08